Preprint · CC-BY
via OpenAlex
Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis
Ghezal Dabiry, Abiya Ahad, Sultan Mujib Dabiry, Tala Nuray Yusufoğlu, Ananya Katoch, Zafer Utku Ulker, Raghad Zaidan
· 2026
Abstract
This scoping review will map and synthesize the existing evidence on thymulin in relation to inflammaging(definition) and cancer, with particular emphasis on its potential role as an immunoregulatory mediator at the intersection of chronic inflammation, immune aging, and tumor biology. The review will examine the available evidence regarding thymulin’s biological functions, its relationship with age-associated immune dysregulation and chronic low-grade inflammation, and its potential involvement in cancer-related immune responses. The review will identify and characterize the existing literature addressing thymulin in the context of aging, inflammaging, cancer development or progression, immune regulation, and related molecular and cellular pathways. Where available, evidence concerning thymulin levels, regulatory mechanisms, cellular targets, signaling pathways, and associations with clinical or biological outcomes will also be mapped. The primary objective is to provide a comprehensive overview of the current state of knowledge, identify areas of convergence and uncertainty, and highlight gaps in the literature that may guide future mechanistic and translational research. Given the emerging nature and heterogeneity of the evidence base, the review will use a scoping review methodology to characterize the breadth, nature, and distribution of available evidence rather than to estimate a pooled effect.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.17605/osf.io/vxrdm
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Dabiry, G., Ahad, A., Dabiry, S.M., Yusufoğlu, T.N., Katoch, A., Ulker, Z.U., & Zaidan, R. (2026). Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis. https://doi.org/10.17605/osf.io/vxrdm
Vancouver
Dabiry G, Ahad A, Dabiry SM, Yusufoğlu TN, Katoch A, Ulker ZU, et al. Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis. 2026. doi:10.17605/osf.io/vxrdm.
BibTeX
@unpublished{ghezal2026Thymul,
title = {Thymulin at the crossroads of inflammaging and Cancer: An emerging immunoregulatory Axis},
author = {Ghezal Dabiry and Abiya Ahad and Sultan Mujib Dabiry and Tala Nuray Yusufoğlu and Ananya Katoch and Zafer Utku Ulker and Raghad Zaidan},
year = {2026},
doi = {10.17605/osf.io/vxrdm},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Periodontology 2000 2026
Open access · CC-BY
From senescence and inflammaging to systemic comorbidities: Drivers of aging‐associated periodontitis
Periodontology 2000 2026
Citation only
From senescence and inflammaging to systemic comorbidities: Drivers of aging-associated periodontitis.
Cancers 2019
Open access · CC-BY
Ionizing Radiation and Complex DNA Damage: From Prediction to Detection Challenges and Biological Significance
Nutrients 2026
Citation only
Inflammaging and Sarcopenia as Interconnected Hallmarks of Aging: Integrative Roles of Bioactive Compounds and Lifestyle Interventions.
Longevity 2025
Open access · CC-BY
The Role of a Healthy Lifestyle and the Interaction of Nutrition and Physical Activity in Slowing Aging and Enhancing Quality of Life: A Systematic Review
Frontiers in medicine 2026
Open access · OA